Kiora Pharmaceuticals Inc (KPRX) — Capital Reinvestment Ratio

Latest as of September 2024: 0.00x

Kiora Pharmaceuticals Inc (KPRX) has a Capital Reinvestment Ratio of 0.00x as of September 2024, meaning it reinvests 0% of its operating cash flow ($920.06K) in capital expenditures ($3.00). See Kiora Pharmaceuticals Inc balance sheet quality to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.00x
Capex / Operating Cash Flow

Operating Cash Flow

$920.06K
USD

Capital Expenditures

$3.00
USD

Data as of

Sep 2024
Most recent filing

Kiora Pharmaceuticals Inc Capital Reinvestment Ratio (2024–2024)

This chart tracks Kiora Pharmaceuticals Inc's Capital Reinvestment Ratio across 1 annual periods. Check how aggressively does Kiora Pharmaceuticals Inc reinvest cash to assess the company's total reinvestment commitment from operating cash flow.

Annual Capital Reinvestment Ratio for Kiora Pharmaceuticals Inc (2024–2024)

Year-by-year Capital Reinvestment Ratio for Kiora Pharmaceuticals Inc from 2024 to 2024. For live market cap and broader valuation context, see market value of Kiora Pharmaceuticals Inc.

Year Reinvestment Ratio Operating CF (USD) Capital Expenditures YoY Change
2024 0.00x $8.56 Million $6.26K
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow